West Pharmaceutical Services, Inc. (WST) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, and welcome to Wes' first quarter earnings conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question-and-answer session. Instructions will be given at that time. Please note, today's call is being recorded. I would like to turn the call over to John Sweeney, Vice President of Investor Relations. Please go ahead. Good morning, and welcome to West's first quarter 2026 earnings conference call, which has been webcast live. With me today on the call are West's President, CEO, and Chairman, Eric Green, and West's Senior Vice President and CFO, Bob McMahon. Earlier today, we issued our first quarter financial results, a copy of the press release, along with today's slide presentation containing supplemental information for your reference has been posted in the investor section of the company's website at investor.westfarmer.com. Later today, a replay of the webcast will also be available in the investor section of our website. Before we begin, we'd like to remind you that statements made by management during this call and in the accompanying presentation contain forward-looking statements within the meaning of U.S. federal securities law. Please refer to the accompanying Safe Harbor statements in today's press release and in addition to other disclosures made by the company, such as our 10-K and 10-Q regarding the risks to which the company is subject. During the call, management will also report on certain non-GAAP financial measures, including organic net sales, adjusted operating profit, adjusted operating profit margin, free cash flow, and adjusted diluted earnings per share. The accompanying disclosure statement, as well as reconciliations of these non-GAAP financial measures to the mo...